The impact of multiple neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: A single center experience
Increasing the number of NACT cycles did not significantly impact OS, PFS, or the overall response to therapy. However, the study's small patient population presents a limitation.
Authors
- Wala Mehros
- Ahmed Shams (ORCID: https://orcid.org/0000-0002-2831-3389)
- Hatim Al-Jifree
- A. El Hinnawi
- Syed Sameer Aga (ORCID: https://orcid.org/0000-0002-8186-1149)
- Rowayd Gobouri
- Omar Alahmary
- Jaser Tashkandi
- Amal Hanjour
- Omar Turkistani
- Amal Al Somairi
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdulaziz Medical City (SA)
- King Abdullah International Medical Research Center (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100904
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00